DSpace Repository

Neurocognitive Impairment for Persons Living with HIV in Peru: A National Physician Survey

Show simple item record

dc.contributor.author Slotkin, R
dc.contributor.author Huff, H
dc.contributor.author Granda Calderón, Camila Lucero
dc.contributor.author Cabera, D
dc.contributor.author Diaz, M
dc.contributor.author Villafane, CMB
dc.contributor.author Hsieh, E
dc.contributor.author Garcia Funegra, Patricia Jannet
dc.date.accessioned 2023-12-05T17:48:03Z
dc.date.available 2023-12-05T17:48:03Z
dc.date.issued 2023
dc.identifier.uri https://hdl.handle.net/20.500.12866/14655
dc.description.abstract Objective: To describe HIV provider screening and management practices for neurocognitive impairment (NCI) in persons living with HIV (PLWH) in Peru. Background: As PLWH on antiretrovirals achieve longer lifespans, they experience an increased risk of non-communicable diseases, in particular NCI. In Peru, 28.5% of PLWH > 40 years old were found to have NCI (Diaz 2021). However, there is no data on Peruvian HIV provider management of NCI. Design/Methods: Public sector physicians affiliated with Peru’s National HIV, STI and Hepatitis Program were identified by the Program’s provider registry and through regional Program coordinator referral. Willing participants completed a telephone survey, which included: (1) socio-demographics (2) comfort level addressing NCI prevention, diagnosis, and treatment (4-point Likert scale: no certainty, little certainty, certain, very certain), (3) NCI screening frequency, and (4) NCI practice patterns (free response). Results: Seventy-eight of 167 identified physicians completed the survey (mean age 45.8±9.3; 26% women; 61% from coastal regions, 18% highlands, 21% jungle; 78% infectious disease specialists). The majority reported lack of comfort (‘no certainty’ or ‘little certainty’) with NCI prevention (59%), diagnosis (53%), and treatment (76%). Comfort level was not associated with any provider sociodemographic characteristics. Sixty-seven percent (52/78) attempted NCI management, 31% (24/78) solely referred to a specialist, and 3% (2/78) did not manage NCI. Management strategies described included: evaluating for contributing opportunistic infections, substance use, or medications (36%), ordering neuroimaging (18%), re-evaluating antiretroviral regimen (17%), performing cognitive assessments (17%), and ruling-out depression (6%). Of physicians who reported at least one of these management strategies, 98% also referred to neurology, psychology, neuropsychology, or geriatrics. Conclusions: Although the majority of physicians reported lack of comfort managing NCI in PLWH, most still engaged in some form of NCI management. There is a need to develop training programs, screening tools, and guidelines to standardize the approach to NCI in PLWH in Peru. Disclosure: Dr. Slotkin has received research support from Fogarty International Center, NIH. Dr. Slotkin has received research support from Yale University/NIH. Dr. Huff has nothing to disclose. Dr. Granda has nothing to disclose. Dr. Cabrera has nothing to disclose. Dr. Diaz has nothing to disclose. Dr. Benites has nothing to disclose. Dr. Hsieh has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American College of Rheumatology. The institution of Dr. Hsieh has received research support from NIH. The institution of Dr. Hsieh has received research support from China Medical Board. The institution of Dr. Hsieh has received research support from Yale Institute for Global Health. The institution of Prof. Garcia has received research support from CDC. The institution of Prof. Garcia has received research support from USAID. The institution of Prof. Garcia has received research support from Interamerican Bank of Development. en_US
dc.language.iso eng
dc.publisher Wolters Kluwer Health
dc.relation.ispartofseries Neurology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Neurocognitive en_US
dc.subject Persons Living with HIV en_US
dc.subject Peru en_US
dc.subject National Physician Survey en_US
dc.subject.mesh Trastornos Neurocognitivos
dc.subject.mesh VIH
dc.subject.mesh Perú
dc.subject.mesh Encuestas y Cuestionarios
dc.title Neurocognitive Impairment for Persons Living with HIV in Peru: A National Physician Survey en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1212/WNL.0000000000203802
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.25
dc.relation.issn 1526-632X


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics